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Abstract
The purpose of this study was to determine the ability of superparamagnetic iron oxide (SPIO) nanoparticles to function as a
long-term tracking label for multi-modal imaging of implanted engineered tissues containing muscle-derived progenitor
cells using magnetic resonance imaging (MRI) and X-ray micro-computed tomography (mCT). SPIO-labeled primary
myoblasts were embedded in fibrin sealant and imaged to obtain intensity data by MRI or radio-opacity information by mCT.
Each imaging modality displayed a detection gradient that matched increasing SPIO concentrations. Labeled cells were
then incorporated in fibrin sealant, injected into the atrioventricular groove of rat hearts, and imaged in vivo and ex vivo for
up to 1 year. Transplanted cells were identified in intact animals and isolated hearts using both imaging modalities. MRI was
better able to detect minuscule amounts of SPIO nanoparticles, while mCT more precisely identified the location of heavily-
labeled cells. Histological analyses confirmed that iron oxide particles were confined to viable, skeletal muscle-derived cells
in the implant at the expected location based on MRI and mCT. These analyses showed no evidence of phagocytosis of
labeled cells by macrophages or release of nanoparticles from transplanted cells. In conclusion, we established that SPIO
nanoparticles function as a sensitive and specific long-term label for MRI and mCT, respectively. Our findings will enable
investigators interested in regenerative therapies to non-invasively and serially acquire complementary, high-resolution
images of transplanted cells for one year using a single label.
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Introduction
Non-invasive imaging techniques can provide important infor-
mation about the retention and distribution of transplanted cells in
experimental therapeutic trials. To acquire useful imaging data, it
is essential to label these cells with a substance that provides the
necessary contrast to enable their identification in whole animals
or specific organs long after their transplantation. While many
contrast agents have been developed for use with individual
imaging systems, numerous situations exist in which it would be
beneficial to employ one agent to provide contrast detectable by
multiple modalities [1]. Several research groups have created or
modified compounds for this purpose [2,3,4,5,6,7]; however, the
utilization of colloidal superparamagnetic iron oxide (SPIO)
particles coated with dextran as a reliable, well-characterized,
and readily-available contrast agent for long-term tracking of
transplanted cells using both magnetic resonance imaging (MRI)
and micro-computed tomography (mCT) has not been described.
In view of that, we evaluated the use of SPIO nanoparticles as a
multi-modal contrast agent to identify progenitor cells within
engineered tissues implanted in the atrioventricular (AV) groove of
Lewis rat hearts for six months and one year.
For over a quarter of a century, the extremely high relaxivity of
iron oxide particles has been exploited to provide strong contrast
in MRI applications [8,9,10,11]. While SPIOs were originally used
for diagnostic purposes, a number of studies demonstrated the
ability of these particles to non-invasively identify and track
transplanted cells by MRI [12,13,14,15]. One key attribute of
SPIO particles is that they are biologically inert and believed to
safely degrade via normal iron recycling pathways when released
from dying cells [16]. Another beneficial feature is that cells can be
heavily-labeled with SPIOs and remain viable without affecting
their proliferative capacity [17]. On the other hand, the
intracellular concentration of SPIO particles can be diluted by
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problems associated with their utilization in cell tracking studies
include the ingestion and removal of labeled cells from target
tissues by macrophages and the persistence of large deposits of iron
particles released from dead and dying transplanted cells [19].
Although it is well established that MRI enables non-invasive
tracking of SPIO-labeled cells with high spatial resolution and
sensitivity as well as superb soft tissue detail, there are few, if any,
studies that evaluate the efficacy of this label beyond a few days or
weeks. In published reports using iron-labeled cells transplanted to
the myocardium, hypointense signals detected by MRI commonly
dissipate over time, which is largely attributable to poor survival
and retention of the transplanted cells [20]. The inability to track
SPIO-labeled cells in the heart over long periods of time is likely
predominantly related to transplanted cell loss as a result of the cell
delivery method and the host tissue micro-environment rather
than the depletion of signal because of immune reactions, iron
metabolism, or dilution from cell proliferation [21,22]. In contrast,
previous studies from our laboratory have demonstrated the
viability and survival of muscle-derived progenitor cells incorpo-
rated within engineered tissue constructs for well over two years
following implantation in the rat heart [23]. As a result, we
presumed our rodent model may be better suited to evaluate the
long-term imaging potential of SPIO-labeled cells using magnetic
resonance-based methods.
SPIO particles are superb contrast agents for MRI because of
their ability to shorten transverse relaxation times (T2 and T2*),
leading to increased signal intensity in target tissues. They also
permit serial tracking of transplanted cells; however, there are
several limitations to imaging these types of compounds. For
instance, labeled regions can be difficult to distinguish from other
areas of negative contrast caused by water-fat interfaces and blood
flow. Moreover, a quantitative assessment of implanted cells
cannot be performed on very hypointense images and the signal
intensity tends to over-estimate the number of transplanted cells
due to the exceptionally high sensitivity of MRI. Consequently, we
wanted to identify other non-invasive imaging modalities that
would complement the sensitivity of MRI-based cell detection with
more precise localization of SPIO-labeled cells. Given that several
imaging techniques have been developed to suppress the well-
documented X-ray computed tomography imaging artifacts
caused by iron-containing metal implants [24,25], we reasoned
that SPIO nanoparticles could be identified using mCT. SPIO
nanoparticles imaged by this technique would generate positive
contrast images, which would be less prone to misinterpretation
when compared to the large amount of negative contrast often
detected by MRI. Because of the anticipated lower sensitivity of
this imaging method, mCT may also avoid the problem of over-
estimating the number of transplanted cells as is the case with T2-
and T2*-weighted MRI. Accordingly, we investigated whether the
combination of MRI and mCT can provide superior information
about the number and position of transplanted iron-labeled cells
than either imaging technique alone.
In this report, we show SPIO nanoparticles function as a long-
term label of transplanted cells in the heart using two comple-
mentary imaging modalities. We found MRI to be a more sensitive
technique and mCT was more precise for detection of SPIO-
labeled cells; however, the combination of these non-invasive
imaging methods provides a powerful new approach to track
transplanted cells in preclinical animal models over extended
periods of time without the need for genetic manipulation of the
delivered cells.
Methods
Myoblast Isolation and Labeling with SPIO Nanoparticles
Primary skeletal myoblasts were isolated from day 2 (d2)
neonatal rats essentially as described [26]. Feridex IV (ferumoxides
injectable solution) (Berlex) was used to label cells as previously
described [13]. Briefly, for every 1.5610
7 cells to be labeled, 27 mg
Poly-L-lysine (PLL) hydrobromide (Sigma) and 0 mg, 0.37 mg,
1.48 mg, 2.30 mg, 4.66 mg, 9.33 mg, 18.67 mg or 37.3 mg of SPIO
particles (i.e. Feridex IV) was added to 9 mL of serum free Ham’s
F-10 culture medium (Thermo Scientific). The solution was mixed
and incubated on a rocking platform at 25uC for 1 hour. The
medium was removed from the culture plates and the cells were
rinsed twice with phosphate buffered saline (PBS), pH 7.4. The
PLL-SPIO mixture was then added dropwise to the cells and the
plates were incubated at 37uC for 1 hour. The PLL-SPIO solution
was aspirated and the cells were rinsed twice with PBS. Ham’s F-
10 medium containing 20% fetal bovine serum (FBS) (Atlanta
Biologicals), 1% penicillin-streptomycin (Life Technologies), and
1% Fungizone (Life Technologies) was added to the cells and
placed in a humidified 37uC incubator supplemented with 5%
CO2. Accustain Iron Staining (Sigma) was performed on 4%
paraformaldehyde (PFA)-PBS fixed cells attached to LabTEK
slides representing each SPIO concentration. Three experiments
were performed for each concentration and images were acquired
using brightfield microscopy.
Incorporation of Cells within Fibrin Sealant
One day after labeling with PLL-SPIO, cells were rinsed twice
with PBS and then detached from the plates using 0.05% trypsin-
EDTA (Life Technologies). For creation of SPIO gradient
standards, approximately 3610
7 cells were collected by centrifu-
gation and resuspended in 30 mL of PBS and mixed with 70 mLo f
the thrombin portion of TISSEEL fibrin sealant (Baxter). A 1 mL
syringe was loaded with thrombin containing the cells. Another
1 mL syringe was loaded with 100 mL of the fibrinogen portion of
TISSEEL fibrin sealant. The Duploject system (provided with
TISSEEL) was used to simultaneously mix and eject the two
solutions into a micro-centrifuge tube. Three tubes were generated
and imaged for each SPIO concentration and three slices from
each acquisition were averaged to collect intensity or opacity data.
For injection into the AV groove of each rat heart, 3610
7 cells
were resuspended in 30 mL of PBS and mixed with TISSEEL as
described above. The Duploject system was used to eject the fibrin
sealant into the AV groove of each rat’s heart.
Rat Model, Cell Implantation, and Heart Extraction
Experimental rat hearts (n=6) were implanted with fibrin
sealant containing SPIO-labeled cells, while control rats (n=3)
were implanted with TISSEEL containing unlabeled cells. Adult
female Lewis rats were pre-anesthetized with 75 mg/kg Ketamine
and 5 mg/kg Xylazine via intraperitoneal (IP) injection followed
by intra-tracheal intubation with an appropriate sized intravenous
(IV) catheter. Animals were connected to a small animal respirator
(Harvard Apparatus INSPIRA) to deliver a mixture of 0.5%
isoflurane and 99.5% oxygen. Respiration rate and stroke volume
were adjusted based on bodyweight. An antero-lateral incision at
the right thoracic wall was performed and the muscular planes
were dissected. The thoracic cavity was entered through the 4
th
intercostal space, the pericardium was opened, and the heart
exposed. The AV groove was identified and the epicardium was
removed on both the right atrium and the right ventricle to reveal
the myocardium. A portion of the cell and fibrin sealant mixture
was applied to this region. The pericardium and the chest wall
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Prolene) and the incision was infiltrated with Bupivicaine.
Pneumothorax was evacuated by insertion of an appropriate sized
catheter. The animals were then extubated after weaning from the
respirator and recovered under analgesia (0.5 mg/kg Buprenor-
phine sub-cutaneously every 12 hours for 3 days). Six months and
one year later, the rats were subjected to MRI and mCT. Hearts
were then excised, rinsed in PBS, perfusion-fixed in 4%
paraformaldehyde and fixed at 4uC using 4% PFA in PBS.
Isolated hearts were also imaged by MRI and mCT. Studies were
carried out in accordance with the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health and our
animal protocol was approved by the Boston Children’s Hospital
IACUC.
Magnetic Resonance Imaging
To acquire images and T2* relaxation times, the cell samples,
Lewis rats, and excised hearts were placed in a BioSpec 70/30
USR 7T MRI System (Bruker) running ParaVision Version 5.1
software or a BioSpec 4.7T MRI system (Bruker) running
ParaVision Version 4.0. Rats were anesthetized with 1.5–2.0%
isoflurane at an oxygen flow of 1 L/minute via nose cone.
Respiration was maintained between 38 and 55 breaths per
minute and ECGs acquired throughout the acquisitions showed
heart rates between 255 and 315 beats per minute. After an initial
positioning scan, multiple-slice, FLASH cine images were acquired
with the following parameters: For animals – pulse repetition time,
52.747 ms; echo time, 1.460 ms; field of view, 60660 mm; slice
thickness, 0.5–1.0 mm; acquisition matrix size, 2566256: For cell
gradients and hearts – pulse repetition time, 300 ms; echo time,
2.4 ms; field of view, 60660 mm; slice thickness, 0.5–1.0 mm;
acquisition matrix size, 2566256. Images were reconstructed and
intensity data was analyzed using ImageJ software (http://imagej.
nih.gov/ij/download.html).
Micro-Computed Tomography
Micro-CT was performed using an Albira Preclinical Imaging
System (Bruker) running Albira Software Suite version 1.530.
Excised hearts were scanned at an X-ray tube voltage and current
of 45 kV and 400 mA, respectively, using 600 projections per scan.
The reconstructed images were 51265126512 voxels with an
isotropic voxel size of 125 mm. SPIO gradient images were
analyzed using the Amide software package (http://amide.
sourceforge.net). Cross sectional and volume rendered images
identifying iron-labeled cells in live rats and excised hearts were
created using VolView, version 3.4 (Kitware).
Histological Staining of Heart Tissue Sections
Excised hearts were retrograde perfused in the constant flow
Langendorff mode at 22uC for 10 min with 4% PFA in PBS prior
to passive fixation at 4uC overnight in the same solution. After
paraffin embedding and sectioning (5 mm thickness), slides were
baked for 1 hour at 65uC, deparaffinized in xylenes, rehydrated
through a graded ethanol series, and subjected to antigen retrieval
by heating three times for 5 min in 1 mM EDTA (pH 8.0) using a
700 W microwave oven set to high. The PBS solution was
changed between each heating cycle. Slides were then used for
either routine histological staining (Masson’s trichrome or Prussian
blue with pararosaniline) or immunohistochemical staining with
the following antibodies: anti-sarcomeric a-actinin (ACTN)
(Abcam ab68167), anti-macrophage (MAC387) (Abcam
ab22506), or anti-cardiac troponin T antibody (cTnT) (Abcam
ab8295). Some slides were fluorescently labeled with Alexa Fluor
488 phalloidin (Life Technologies). Primary antibodies were
detected with species appropriate highly cross-adsorbed Alexa
Fluor-conjugated secondary antibodies (Life Technologies),
stained with 49,6-diamidino-2-phenylindole (DAPI) (Life Technol-
ogies), and visualized with an Olympus FSX-100 fluorescent
microscope.
Statistical Analyses
The percentage of Prussian blue stained cells was determined by
three blinded observers for each iron oxide concentration. For
MRI and mCT detection of SPIO-labeled cells, three slices from
each image acquisition were combined to collect mean T2*
relaxation times and pixel intensity or voxel opacity data,
respectively. Values were generated using SigmaPlot 12.5 statis-
tical analysis software and significance was determined using a
paired t-test. These values are reported as mean 6 standard error
of the mean and a P,0.05 was considered significant.
Results
Creation of a SPIO-Labeled Cell Gradient
Our initial experiments focused on determining the amount of
Feridex reagent needed to efficiently label cells in culture and
remain detectable by histology, MRI, and mCT. Accordingly,
primary rat myoblasts were seeded onto microscope slides and
labeled with increasing amounts of SPIOs. One day after labeling,
the cells were fixed and stained for the presence of iron
(Figure 1A). For each SPIO concentration, five images from three
experiments were acquired and enumerated by blinded observers
to establish the proportion of labeled cells. Data points for each
concentration represent the mean percentage of labeled cells 6
standard error of the mean. In this way, we determined
approximately 80% of the myoblasts were labeled at the 4.66 pg
per cell SPIO concentration and 100% of the cells were labeled at
the 37.33 pg per cell SPIO concentration. SPIO concentrations.
1.48 pg per cell showed P-values,0.01 when compared to
unlabeled cells or those exposed to 0.37 pg per cell.
Assessment of SPIO-Labeled Cell Standards by MRI
For each concentration of SPIO particles, a total of 3610
7 cells
were labeled, mixed with fibrin sealant, and injected into micro-
centrifuge tubes. The cells for each tube (using three tubes per
concentration) were distributed evenly within the fibrin matrix to
create a total volume of 200 mL. Cross sectional images of the
cellular organization in these tubes and T2* relaxation times for
those areas were acquired using MRI (Figure 1B). Escalating
negative contrast (i.e. hypointensity) was observed to correspond
with increases in the number of SPIO particles used to label cells
in each tube. Our data showed complete saturation of signal by
MRI in tubes containing cells labeled at a concentration of 1.48 pg
SPIO particles or more per cell. As expected, T2* relaxation times
and pixel intensities were closely correlated. For both T2*
relaxation data as well as pixel intensity data, SPIO concentrations
$1.48 pg per cell showed P-values,0.01 when compared to those
cells exposed to concentrations #1.48 pg per cell. Data points for
each concentration represent mean T2* relaxation (ms) 6
standard error of the mean (left panel) or mean pixel intensity 6
standard error of the mean (right panel).
Assessment of SPIO-Labeled Cell Standards by mCT
The same SPIO standards used in the MRI study were imaged
using mCT (Figure 1C). Using this imaging method, enhanced
signal from iron oxide was manifest as regions of positive contrast
(i.e. hyperintensity), which corresponded to the increasing SPIO
particle concentrations in the cells in each tube. While opaque,
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9.33 pg per cell concentrations, the 18.67 pg concentration
generated a signal that was more readily apparent and likely to
be detectable in vivo. In contrast to MRI detection of SPIOs, mCT
imaging identified only those cells that contain relatively large
deposits of iron. Although this imaging modality was less sensitive
to lower SPIO concentrations, it did appear to more precisely
identify the location of heavily-labeled cells and resulted in a
linearity of detection comparable to that observed for Prussian
blue-stained cells (Figure 1A) when compared to MRI (Figure 1B).
SPIO concentrations $4.66 pg per cell showed P-values,0.01
when compared to those cells exposed to concentrations #4.66 pg
Figure 1. In vitro detection of SPIO nanoparticle-labeled muscle progenitor cells by histology, MRI, and mCT. A) Cells incubated with
increasing concentrations of SPIO particles and PLL were fixed and stained with Prussian blue and pararosaniline to identify iron-labeled cells. Slides
were imaged using brightfield microscopy. The graph shows the percentage of SPIO-labeled cells at each concentration (mean 6 standard error of
the mean) as determined by analysis from three blinded observers. B) MRI of SPIO-labeled cell standards incorporated within fibrin sealant in micro-
centrifuge tubes. The graphs display T2* relaxation time versus SPIO concentration (left) and average pixel intensity versus SPIO concentration (right)
as determined from mean values generated from three different labeling experiments. C) mCT images of the same SPIO-labeled cell standards
incorporated within fibrin sealant as depicted in B). The graph displays the number of opaque voxels versus SPIO concentration as determined from
values generated from three different labeling experiments. Data represents mean 6 standard error of the mean for each.
doi:10.1371/journal.pone.0108695.g001
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standard error of the mean.
MRI and mCT of Implanted SPIO-labeled Cells within
Engineered Tissues
Two days after isolation from neonatal rat skeletal muscle,
myoblasts were incubated with 18.67 pg of SPIO particles per cell,
mixed with fibrin sealant, and injected into the AV groove of rat
hearts. Six months and one year after implantation, live animals or
isolated hearts were assessed in vivo using each non-invasive
imaging modality. As expected, MRI revealed hypointense regions
where the SPIO-labeled cells were located in live rats (Figure 2A
and B) (Movie S1 and S2) or in excised, fixed hearts (Figure 2C)
using either a 4.7T or 7T magnet for acquisition. mCT imaging
revealed positive contrast regions indicating the location of
heavily-labeled cells, which was clearly noticeable in both cross
sectional images and volumetric renderings from the in vivo
acquisition from live rats 6 months after implantation surgery
(Figure 3, A to C) (Movie S3) as well as from isolated hearts one
year post-implantation (Figure 4A–C) (Movie S4). Control hearts
did not show any equivalent hypointense signals by MRI or
hyperintense signals by mCT (not shown). These signals were only
noticeable in the experimental animals and excised hearts. MRI
Figure 2. Localization of SPIO-labeled cells in implanted rat hearts by MRI. A) Arrows indicate the location of hypointense regions resulting
from the presence of SPIO nanoparticles contained in the implant. Coronal (left), axial (center), and sagittal (left) MRI slices from in vivo cardiac
imaging acquisitions were obtained 6 months post-implantation using a 7T magnet. B) Arrows indicate the location of SPIO-labeled cells
(hypointense region) in short-axis slices from in vivo cardiac acquisitions taken from two different rats at 6 months and 1 year after surgical
implantation of engineered tissues, respectively. These images were obtained using a 4.7T magnet. C) Arrows indicate the location of iron-labeled
cells within the implant in an isolated heart that had been implanted with engineered tissues for 1 year. These coronal (left) and axial (right) MRI slices
correspond to the in vivo images shown in A).
doi:10.1371/journal.pone.0108695.g002
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B); however, there was no difference in the results acquired from
either system.
Histology of SPIO-labeled Cells in Implanted Engineered
Tissues
The fixed hearts (Figure 5A, left panel) were embedded in
paraffin, sectioned coronally, and stained with Masson’s trichrome
to distinguish cells (red) from connective tissue (blue) (Figure 5A,
middle panel). Closer inspection of Masson’s trichrome stained
sections revealed that iron-labeled cells (greenish-brown) could be
identified in the area of the implant. This observation was
confirmed using Prussian blue and pararosaniline staining of
adjacent serial sections (Figure 5A right panel). Higher magnifi-
cations of the implanted region identified in Figure 5A showed the
vast majority of iron staining was confined to the myoblast
cytoplasm (Figure 5B). A few rare deposits of iron appeared
outside the myoblast plasma membrane and likely represent SPIO
particles that were never internalized by the cells. We also found
brightfield illumination alone was able to identify heavily-labeled
cells (Figure 5B, left panel) and the presence of iron was confirmed
in serial sections stained with Masson’s trichrome and Prussian
blue (Figure 5, middle and right panels). The heart sections in
Figure 5 (A to C) correspond to the MRIs in Figure 2 (A and C)
and the mCT images shown in Figures 3 and 4. Although we
Figure 3. Localization of SPIO-labeled cells in whole animals by mCT. A) Arrows indicate the location of the SPIO nanoparticle-labeled muscle
progenitors contained within engineered tissues that were implanted in the AV groove of an adult rat heart for 1 year. Unlike MRI images, the iron
presents as a positive contrast or hyperintense signal. Coronal (A), axial (B), and sagittal (C) mCT images are shown. The panels on the left show
individual mCT image slices, while the panels on the right depict the corresponding volumetric renderings from all of the acquired slices. These
renderings were set to a threshold level that permitted simultaneous visualization of bone and iron-labeled cells. This processing resulted in loss of
some soft tissue detail.
doi:10.1371/journal.pone.0108695.g003
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(Figure 5D), the combination of MRI, mCT, and histology from
this particular heart demonstrated the sensitivity and precision of
the two imaging modalities in identifying and localizing a small
cluster of iron-labeled cells.
To confirm the labeled cells in tissue sections represented viable
myoblasts and to look for the presence of infiltrating macrophages,
we stained serial sections with MAC387, ACTN, and cTnT along
with DAPI (Figure 5C). We found very few macrophages in the
implants; though, some macrophages were identified in other
regions of the heart (Figure 5C, left panel inset). There was no
evidence at one year of macrophage ingestion of SPIO nanopar-
ticle-labeled myoblasts. As expected, labeled cells did stain with the
general muscle marker ACTN, but did not stain for cardiac-
specific cTnT (Figure 5C, left and middle panels). For compar-
ison, a region of right ventricular myocardium stained for both
ACTN and cTnT (Figure 5C, right panel). In a different heart, we
found large numbers of iron-labeled cells that were restricted to
the region of the implant and showed a similar staining pattern to
that described above (Figure 5D). Therefore, our histological
analyses confirmed the presence of SPIO nanoparticle-labeled,
skeletal muscle-derived cells in the expected area based on
observations in vivo and in excised hearts using MRI and mCT
one year following implantation.
Evaluation of over 400 slides from each of the implanted hearts
showed similar results, while control hearts showed no indication
Figure 4. Localization of SPIO-labeled cells in excised hearts by mCT. A) Arrows indicate the location of the SPIO nanoparticle-labeled muscle
progenitors contained within engineered tissues that were implanted in the AV groove of an adult rat heart for 1 year. Signal from iron is shown as a
positive contrast signal (white spot). The asterisk indicates the position of the aorta exiting the heart. Coronal (A), axial (B), and sagittal (C) mCT images
are shown. Once again, the panels on the left show individual image slices and the panels on the right show corresponding volumetric renderings. In
the absence of signal from bone, soft tissue detail becomes more apparent.
doi:10.1371/journal.pone.0108695.g004
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implant in a heart excised one year after implantation (left panel), a low magnification image of a Masson’s trichrome stained heart section (center
panel), and a low magnification image from an adjacent serial section showing Prussian blue iron stain (right panel) of SPIO-labeled cells within the
implant. The right atrium (RA), right ventricle (RV), and aorta are depicted along with an outline of the implant (dotted line). Scale bars equal 500 mm.
B) Higher magnification brightfield images from the boxed region in A) showing an unprocessed serial section demonstrating iron (brown) can be
detected in the cells of the implant and the same Masson’s trichrome and Prussian blue stained sections from A). Scale bars equal 50 mm. C) The same
section as the left panel from B) immunostained for the presence of macrophages (MAC387 in green), DNA (DAPI in blue), and striated muscle (ACTN
in red) (left panel). Adjacent serial sections were immunostained for cardiac troponin T (cTnT in red), DNA (DAPI in blue), and striated muscle (ACTN in
green) (middle panel). The right panel shows an image of ACTN, cTnT, and DAPI staining in the right ventricle. Scale bars equal 50 mm. D) Serial
sections from a different heart stained for Masson’s trichrome (left panel), Prussian blue with pararosaniline (middle panel), and immuno-fluorescence
from secondary antibodies detecting binding of cTnT and ACTN antibodies in addition to DAPI staining of DNA. Iron is abundant in implanted cells,
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many of the skeletal muscle-derived cells one year after
implantation (Figure 6). A few cells that appeared to be
macrophages were identified in one section; however, these
infiltrating cells did not overlap with SPIO-labeled myoblasts
(Figure 6A, arrows). Higher magnification images of heavily-
labeled cells showed that iron deposits identified by brightfield
illumination overlapped with filamentous-actin staining by phal-
loidin and, in some instances, large iron deposits appeared to
displace the cytoskeleton (Figure 6B). Nevertheless, the larger iron
deposits that accounted for the signals acquired by MRI and mCT
always appeared to be contained in viable cells that stained for
ACTN and were never found outside the region of the implant
(Figure 6C).
Discussion
While the use of SPIO nanoparticles as a highly effective
contrast agent for MRI has been reported by numerous groups,
their use as a cellular label for computed tomography has only
been demonstrated by a few other laboratories at early time points
(hours to days) [5][27]. Since methods have been developed to
suppress computed tomography acquisition artifacts in humans
with iron-containing implantable medical devices [24,25], it is not
but is not apparent in the epicardium or myocardium of the right ventricle. The location of SPIO-labeled cells corresponds to the location of ACTN
positive (red), cTnT negative (green) cells. Scale bars equal 50 mm.
doi:10.1371/journal.pone.0108695.g005
Figure 6. SPIO nanoparticle-labeled cells located within the implant in three different hearts. A) Brightfield, fluorescence, and merged
images showing iron deposits in progenitor cells contained within the implant (left panel), staining of filamentous actin with phalloidin (green) and
DNA (blue) (middle panel) in the same section, and the merged image (right panel). Arrows indicate a few inflammatory cells that are not positive for
iron. Scale bars equal 50 mm. B) A different heart showing heavily-labeled cells in the implant using the same staining as described for A). Scale bars
equal 25 mm. C) Iron was also evident (brown) within a portion of the implant immediately adjacent to the right ventricular epicardium in a separate
tissue section (left panel) that was immunostained for ACTN (red) and DAPI (blue) (middle panel). The right panel shows an overlay of the two images
to the left. Scale bars equal 25 mm.
doi:10.1371/journal.pone.0108695.g006
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identified by mCT. For this reason, we suspected that the
combination of MRI and mCT would offer complementary
information for tracking cells in vivo. In the present study, we
established that mCT enabled precise localization of iron-labeled
cells in the heart, although this imaging modality was less sensitive
than MRI. We also extended the effective imaging window to 1
year, which should allow for thorough assessment of preclinical,
cell-based therapies directed at regenerating or repairing the heart.
In addition to identifying the amount of SPIO nanoparticles
necessary for transplanted cell visualization by MRI and mCT, we
also determined the detection limits of iron within labeled cells by
histology (Figure 1). Our experiments established the number of
SPIO nanoparticles necessary to completely label muscle-derived
cells in culture. Similar to the findings of other investigators, we
observed no apparent loss of cellular proliferative capacity or
viability, even in heavily-labeled myoblasts [18,28]. Using MRI, a
SPIO concentration of 1.48 pg per cell so dramatically increased
the proton relaxivity of the entire 200 mm
3 volume of cellularized
fibrin sealant that the pixel intensity was at a maximum (i.e. black).
By comparison, mCT provided much more precise information
regarding the location of heavily-labeled cells and the signal
presented as largely unsaturated positive contrast (i.e. white).
Because a SPIO nanoparticle concentration of 18.67 pg per cell
provided a strong and localized signal by mCT, we chose this
particular labeling concentration for our animal implantation
experiments.
SPIO nanoparticle-labeled progenitor cells were incorporated in
fibrin sealant and injected into the AV groove of Lewis rat hearts
for 1 year. Because we were primarily interested in long-term
tracking of transplanted cells, we imaged these animals at 6
months and 1 year following surgery. We were able to locate the
cells both in vivo and ex vivo using MRI (Figure 2) and mCT
(Figures 3 and 4). For the mCT experiments, we presented results
from the rat heart that contained the fewest number of labeled
cells localized to a discreet region within the implant to
demonstrate the clarity and precision of this technique in
identifying small numbers of cells. Imaging results were confirmed
by extensive histological examination of serial tissue sections from
the same heart (Figure 5) as well as from the other implanted
hearts (Figures 5 and 6). Importantly, these experiments mimicked
a preclinical cell delivery study where it would be critical for a
label to remain intact for a period of months or years. The rare
appearance extracellular SPIO particles observed in histological
sections was presumed to be due to particles that remained
attached to the plasma membrane of cells during the initial
labeling procedure or represented unincorporated nanoparticles
that were not removed during washing of the culture plates.
Overall, our imaging experiments and histological analyses
unequivocally demonstrate the utility of complementary MRI
and mCT for long-term, non-invasive tracking of transplanted
cells.
The present study should dispel the notion that imaging of
SPIO-labeled cells over time using MRI (and mCT) is prone to
excessive false positive or negative (i.e. type I and type II) errors
because acquired signals may not accurately reflect the position
and viability of cells in situ or the contrast provided by the label
deteriorates after a few days or weeks [19]. To circumvent the
release of iron particles from dying cells, ingestion of labeled cells
by macrophages, and dilution of SPIOs by mitosis, we implanted
Feridex-labeled cells incorporated in engineered tissues in the
hearts of syngeneic Lewis rats. Although, we did not specifically
enumerate cell death in vivo, viable myoblasts were easily detected
for one year by histological examination. The cells used for these
experiments were largely post-mitotic, which resulted in little
diminishment of signal from dilution of intracellular iron oxide. In
addition, transplanted myoblasts elicited a negligible immune
response as measured at 6 months and 1 year.
In our earlier studies using a similar experimental protocol, we
showed a modest inflammatory cell infiltration in the region of the
implant that disappeared after a few weeks. This reaction did not
significantly impact the retention of cells transplanted into the
heart [23]. Additionally, the delivery of labeled cells by means of
surgical placement of engineered tissues tends to avoid the high
shear forces experienced by cells that are directly injected into the
ventricular myocardium through small gauge needles. The
Duploject system used for cell delivery has a very wide-bore
fitting that greatly minimizes exposure of cells to excessive shear
stress. Moreover, the engineered tissues were implanted into hearts
that had not been injured prior to implantation (e.g. by myocardial
infarction) [23,28]. In short, the method of delivery, the
anatomical position of the implant, and the health of the target
organ all contributed to the survival of the progenitor cells over a
long period of time [23,29].
Despite the potential for the application of MRI and mCT to
cell-based regenerative medicine studies, we recognize there are
certain obstacles associated with routine use of these non-invasive
imaging modalities. These are largely associated with the cost of
performing repeated, multiple MRI and mCT scans in addition to
limited access to this type of equipment. As far as clinical trials are
concerned, exposure of humans to high levels of ionizing radiation
from X-ray computed tomography is undesirable, particularly in
the pediatric patient population. On the other hand, the
continuing development of these and other imaging systems may
result in greater availability and safety. As cell-based therapies
move from preclinical testing using animal models to human trials,
the need for serial evaluations of patients may also decline. Either
way, if MRI and mCT availability increases in the research setting,
the ability to combine information derived from multiple imaging
modalities will represent a considerable opportunity for research-
ers interested in regenerative medicine.
Conclusions
Here, we present data demonstrating the utility of SPIO
nanoparticles as a long-term, non-genetic label for non-invasive
cell tracking. We identified the detection limits for this contrast
agent using MRI and mCT and precisely localized labeled cells
within engineered tissues implanted in the heart for up to one year.
Detection of transplanted cells labeled with SPIO nanoparticles in
animals and isolated hearts was found to be exceedingly sensitive
and specific using a combination of these imaging modalities. We
believe use of these complementary techniques has immediate
relevance for preclinical testing of cell-based therapies [16].
Supporting Information
Movie S1 Whole animal, coronal MRI movie of SPIO-
labeled cells implanted in a rat heart for 6 months. The
SPIO-labeled implant is the black spot located on the upper left-
hand portion of the heart above the right ventricle and beneath
the right atrium that does not disappear throughout the cardiac
cycle. Other hypointense regions that are caused by blood flow
typically do disappear as blood is pumped out of each chamber.
(AVI)
Movie S2 Whole animal, short axis MRI movie of SPIO-
labeled cells implanted in a rat heart for 6 months. The
SPIO-labeled implant is the black spot located on the upper left
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atrium that does not disappear throughout the cardiac cycle. This
movie corresponds to the still image shown in Figure 2B (left
panel).
(AVI)
Movie S3 Whole animal, volume rendered movie from
serial mCT images of SPIO-labeled cells implanted in a
rat heart for 1 year. The implant is the small white object
located within the thoracic cavity that can be easily identified
within the rib cage. This movie corresponds to the histological
sections depicted in Figure 5 (A to C) and closely approximates the
size, shape, and location of heavily-labeled cells in the implant.
(MPG)
Movie S4 Isolated heart, volume rendered movie from
serial mCT images of SPIO-labeled cells implanted in a
rat heart for 1 year. The iron-labeled cells in the AV groove
are depicted in red. As confirmed by histological examination, the
positive signal emanates from a region between the right atrium
and the aorta, above the right ventricle.
(MPG)
Acknowledgments
We acknowledge Dr. Yaotang Wu of the BCH Small Animal Imaging
Laboratory as well as M. Reza Akhavan-Sharif and Dr. Deborah Burstein
of the BIDMC Preclinical MRI Core Facility for their assistance with MRI;
Patricia Dunning and Erin Snay of the BCH Small Animal Imaging
Laboratory for their assistance with mCT; and Jared Powers, Alexandra
Jenkins, Blake Neyland, Izabelle Mazeto, and Jerusha K. Thedsana-
moorthy for their assistance with histological analyses.
Author Contributions
Conceived and designed the experiments: CAP PEH DBC. Performed the
experiments: CAP PEH AAM RPD KRW AM BS JDM DBC. Analyzed
the data: CAP PEH DBC. Contributed reagents/materials/analysis tools:
PEH DBC. Wrote the paper: CAP PEH AAM RPD KRW AM JDM
DBC.
References
1. Jennings LE, Long NJ (2009) ‘Two is better than one’ – probes for dual-modality
molecular imaging. Chem Commun (Camb) 24: 3511–3524.
2. Xiao M, Nyagilo J, Arora V, Kulkarni P, Xu D, et al. (2010) Gold nanotags for
combined multi-colored Raman spectroscopy and x-ray computed tomography.
Nanotechnology 21: 035101.
3. van Tilborg GA, Vucic E, Strijkers GJ, Cormode DP, Mani V, et al. (2010)
Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence
imaging of atherosclerotic plaques. Bioconjug Chem 21: 1794–1803.
4. Torres Martin de Rosales R, Tavare R, Glaria A, Varma G, Protti A, et al.
(2011) (
99m)Tc-bisphosphonate-iron oxide nanoparticle conjugates for dual-
modality biomedical imaging. Bioconjug Chem 22: 455–465.
5. Torrente Y, Gavina M, Belicchi M, Fiori F, Komlev V, et al. (2006) High-
resolution X-ray microtomography for three-dimensional visualization of human
stem cell muscle homing. FEBS Lett 580: 5759–5764.
6. Kim D, Yu MK, Lee TS, Park JJ, Jeong YY, et al. (2011) Amphiphilic polymer-
coated hybrid nanoparticles as CT/MRI dual contrast agents. Nanotechnology
22: 15910–15930.
7. Bartling SH, Budjan J, Aviv H, Haneder S, Kraenzlin B, et al. (2011) First
multimodal embolization particles visible on X-ray computed tomography and
magnetic resonance imaging. Invest Radiol 46: 178–186.
8. Weissleder R, Hahn PF, Stark DD, Rummeny E, Saini S, et al. (1987) MR
imaging of splenic metastases: ferrite-enhanced detection in rats. AJR
Am J Roentgenol 149: 723–726.
9. Saini S, Stark DD, Hahn PF, Wittenberg J, Brady TJ, et al. (1987) Ferrite
particles: a superparamagnetic MR contrast agent for the reticuloendothelial
system. Radiology 162: 211–216.
10. Saini S, Stark DD, Hahn PF, Bousquet JC, Introcasso J, et al. (1987) Ferrite
particles: a superparamagnetic MR contrast agent for enhanced detection of
liver carcinoma. Radiology 162: 217–222.
11. Bacon BR, Stark DD, Park CH, Saini S, Groman EV, et al. (1987) Ferrite
particles: a new magnetic resonance imaging contrast agent. Lack of acute or
chronic hepatotoxicity after intravenous administration. J Lab Clin Med 110:
164–171.
12. Walter GA, Cahill KS, Huard J, Feng H, Douglas T, et al. (2004) Noninvasive
monitoring of stem cell transfer for muscle disorders. Magn Reson Med 51: 273–
277.
13. Cahill KS, Gaidosh G, Huard J, Silver X, Byrne BJ, et al. (2004) Noninvasive
monitoring and tracking of muscle stem cell transplants. Transplantation 78:
1626–1633.
14. Bulte JW, Kraitchman DL (2004) Iron oxide MR contrast agents for molecular
and cellular imaging. NMR Biomed 17: 484–499.
15. Bulte JW, Kraitchman DL (2004) Monitoring cell therapy using iron oxide MR
contrast agents. Curr Pharm Biotechnol 5: 567–584.
16. Kedziorek DA, Kraitchman DL (2010) Superparamagnetic iron oxide labeling
of stem cells for MRI tracking and delivery in cardiovascular disease. Methods
Mol Biol 660: 171–183.
17. Oude Engberink RD, van der Pol SM, Dopp EA, de Vries HE, Blezer EL (2007)
Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR
detection and cell function. Radiology 243: 467–474.
18. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, et al. (2003)
Characterization of biophysical and metabolic properties of cells labeled with
superparamagnetic iron oxide nanoparticles and transfection agent for cellular
MR imaging. Radiology 229: 838–846.
19. Cianciaruso C, Pagani A, Martelli C, Bacigaluppi M, Squadrito ML, et al.
(2014) Cellular magnetic resonance with iron oxide nanoparticles: long-term
persistence of SPIO signal in the CNS after transplanted cell death.
Nanomedicine (Lond) May 30: 1–18.
20. Chen IY, Greve JM, Gheysens O, Willmann JK, Rodriguez-Porcel M, et al.
(2009) Comparison of optical bioluminescence reporter gene and super-
paramagnetic iron oxide MR contrast agent as cell markers for noninvasive
imaging of cardiac cell transplantation. Mol Imaging Biol 11: 178–187.
21. Campbell NG, Suzuki K (2012) Cell delivery routes for stem cell therapy to the
heart: current and future approaches. J Cardiovasc Transl Res 5: 713–726.
22. Nunes SS, Song H, Chiang CK, Radisic M (2011) Stem cell-based cardiac tissue
engineering. J Cardiovasc Transl Res 4: 592–602.
23. Choi YH, Stamm C, Hammer PE, Kwaku KF, Marler JJ, et al. (2006) Cardiac
conduction through engineered tissue. Am J Pathol 169: 72–85.
24. Glover GH, Pelc NJ (1981) An algorithm for the reduction of metal clip artifacts
in CT reconstructions. Med Phys 8: 799–807.
25. Boas FE, Fleischmann D (2011) Evaluation of two iterative techniques for
reducing metal artifacts in computed tomography. Radiology 259: 894–902.
26. Pacak CA, Cowan DB (2009) Fabrication of myogenic engineered tissue
constructs. J Vis Exp 27: e1137.
27. Emmert MY, Weber B, Wolint P, Frauenfelder T, Zeisberger SM, et al. (2013)
Intramyocardial transplantation and tracking of human mesenchymal stem cells
in a novel intra-uterine pre-immune fetal sheep myocardial infarction model: a
proof of concept study. PLOS ONE 8: e57759.
28. Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, et al. (2003) Clinically
applicable labeling of mammalian and stem cells by combining superparamag-
netic iron oxides and transfection agents. Radiology 228: 480–487.
29. Sill B, Alpatov IV, Pacak CA, Cowan DB (2009) Implantation of engineered
tissue in the rat heart. J Vis Exp 28: e1139.
Long-Term, Non-Invasive Tracking of Transplanted SPIO-Labeled Cells
PLOS ONE | www.plosone.org 11 September 2014 | Volume 9 | Issue 9 | e108695